CD274 and triple-negative breast carcinoma: Furthermore, ribavirin has been suggested to inhibit GBM growth and enhance the effectiveness of chemo-radiotherapy [41,42], reduce chemo-resistant tumor growth of triple negative breast cancer [43], and promote the expression of PD-L1 in cancer cells without impairing the efficacy of immunotherapy [44].